期刊文献+

Mechanism of Traditional Chinese Medicine on Intestinal Mucosal Immunity in Chronic Intestinal Diseases 被引量:3

Mechanism of Traditional Chinese Medicine on Intestinal Mucosal Immunity in Chronic Intestinal Diseases
原文传递
导出
摘要 Although irritable bowel syndrome(IBS) and inflammatory bowel disease(IBD) are clinically common diseases with unclear pathogenesis, both of them are related to the immune system. With progress in studies on their pathogenesis, the two diseases are currently believed to be associated with the presence of intestinal inflammation and intestinal mucosal immune disorder. In recent years, a new approach for the prevention and treatment of chronic intestinal disease is to protect the complete structure and normal immunity of the intestinal mucosal barrier during the treatment of intestinal diseases. However, traditional Chinese medicine(TCM) may have more advantages in regulating the imbalance of the intestinal immune microenvironment, as various single herbs and compounds of TCM have been investigated from the perspective of immune regulation. The use of TCM is prevalent in China. The effectiveness of these therapies appears to be supported by preliminary evidence and clinical experience, although the mechanisms that underlie these effects will require further research. In this paper, with common chronic bowel diseases including IBS, ulcerative colitis and Crohn's disease as the research objects, the relationship between TCM and immunity was explored from the perspectives of the pathogenesis of intestinal mucosal immune injury, the correlation between TCM syndromes and immune disorders, and TCM immune regulation. Moreover, the problems and limitations of the present study were pointed out, and several suggestions were proposed. The purpose of this article is to explore the potential mechanism of TCM on intestinal mucosal immunity in chronic intestinal diseases. Although irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are clinically common diseases with unclear pathogenesis, both of them are related to the immune system. With progress in studies on their pathogenesis, the two diseases are currently believed to be associated with the presence of intestinal inflammation and intestinal mucosal immune disorder. In recent years, a new approach for the prevention and treatment of chronic intestinal disease is to protect the complete structure and normal immunity of the intestinal mucosal barrier during the treat-ment of intestinal diseases. However, traditional Chinese medicine (TCM) may have more advantages in regulating the imbalance of the intestinal immune microenvironment, as various single herbs and compounds of TCM have been investigated from the perspective of immune regulation.The use of TCM is prevalent in China. 吀e effectiveness of these therapies appears to be supported by preliminary evidence and clinical experience, although the mechanisms that underlie these effects will require further research. In this paper, with common chronic bowel diseases including IBS, ulcerative colitis and Crohn's disease as the research objects, the relationship between TCM and immunity was explored from the perspectives of the pathogenesis of intestinal mucosal immune injury, the correlation between TCM syndromes and immune disorders, and TCM immune regulation. Moreover, the problems and limitations of the present study were pointed out, and several suggestions were proposed. The purpose of this article is to explore the potential mechanism of TCM on intestinal mucosal immunity in chronic intestinal diseases.
出处 《World Journal of Traditional Chinese Medicine》 2017年第2期20-30,共11页 世界中医药杂志(英文)
基金 supported by Major State Basic Research Development Program of China (973 Program) (No.2013CB531703) the General Program of National Nature Science Foundation of China (No. 81373580, 81503567 and 81173209) the Visiting Scientist Program of China Academy of Chinese Medical Sciences (No. ZZ070801)
关键词 Irritable Bowel Syndrome Inflammatory Bowel Disease Immune Disorder TCM Immune Regulation Irritable Bowel Syndrome Inflammatory Bowel Disease Immune Disorder TCM Immune Regulation
  • 相关文献

参考文献5

二级参考文献104

  • 1唐利文,莫新民.三黄丸对溃疡性结肠炎大鼠模型组织TNF-α、IL-6、IL-8的影响[J].中医药导报,2005,11(5):67-68. 被引量:9
  • 2邓辉,钦丹萍.中医药对溃疡性结肠炎细胞因子的干预研究[J].中国中西医结合消化杂志,2006,14(5):344-346. 被引量:8
  • 3Jesus K Yamamoto-Furusho.Innovative therapeutics for inflammatory bowel disease[J].World Journal of Gastroenterology,2007,13(13):1893-1896. 被引量:10
  • 4Drossman DA.The functional gastrointestinal disorders and the Rome III process.Gastroenterology 2006; 130:1377-1390.
  • 5Hasler WL,Owyang C.Irritable bowel syndrome.In:Yamada T,ed.Textbook of Gastroenterology.2nd ed.Philadelphia:Lippincott,1995:1832-1855.
  • 6Dunlop SP,Jenkins D,Spiller RC.Distinctive clinical,psychological,and histological features of postinfective irritable bowel syndrome.Am J Gastroenterol 2003; 98:1578-1583.
  • 7Kim HS,Kim MS,Ji SW,Park H.[The development of irritable bowel syndrome after Shigella infection:3 year follow-up study] Korean J Gastroenterol 2006; 47:300-305.
  • 8Ilnyckyj A,Balachandra B,Elliott L,Choudhri S,Duerksen DR.Post-traveler's diarrhea irritable bowel syndrome:a prospective study.Am J Gastroenterol 2003; 98:596-599.
  • 9Rodríguez LA,Ruigómez A.Increased risk of irritable bowel syndrome after bacterial gastroenteritis:cohort study.BMJ 1999; 318:565-566.
  • 10Ruigómez A,García Rodríguez LA,Panés J.Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice:influence of comorbidities.Clin Gastroenterol Hepatol 2007; 5:465-469.

共引文献122

同被引文献73

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部